Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey

Table 3 Other specific requirements and conditions for contact precaution (CP)

MDRO	Origin of responses	Total responses	Additional pre-emptive CP based on patient’s history^a	CP only required if specific risk factors present^b	Additional pre-emptive CP but only if specific risk factors	None applicable	p-value^c
MRSA	EU	126	117 (92.9)	1 (0.8)	1 (0.8)	7 (5.6)	0.038
MRSA	Non EU	38	30 (78.9)	1 (2.6)	2 (5.3)	5 (13.2)	0.038
GRE	EU	94	81 (86.2)	3 (3.2)	1 (1.1)	9 (9.6)	0.265
GRE	Non EU	30	24 (80.00)	2 (6.7)	2 (6.7)	2 (6.7)	0.265
ESBL E. coli	EU	91	74 (81.3)	8 (8.8)	4 (4.7)	5 (4.7)	0.812
ESBL E. coli	Non EU	26	22 (84.6)	1 (3.8)	2 (7.7)	1 (3.8)	0.812
ESBL non-E. coli	EU	101	86 (85.1)	5 (5.0)	3 (3.0)	7 (6.9)	0.131
ESBL non-E. coli	Non EU	23	18 (78.3)	3 (13.0)	2 (8.7)	0 (0.0)	0.131
Carbapenem resistant E. coli	EU	120	103 (85.8)	4 (3.3)	4 (3.3)	9 (7.5)	0.465
Carbapenem resistant E. coli	Non EU	36	33 (91.7)	0 (0.0)	2 (5.6)	1 (2.8)	0.465
Carbapenem resistant Enterobacteriaceae (non-E. coli)	EU	126	111 (88.1)	2 (1.6)	4 (3.2)	9 (7.1)	0.560
Carbapenem resistant Enterobacteriaceae (non-E. coli)	Non EU	37	33 (89.2)	1 (2.7)	2 (5.4)	1 (2.7)	0.560
MDR P. aeruginosa	EU	112	96 (85.7)	3 (2.7)	4 (3.6)	9 (8.0)	0.178
MDR P. aeruginosa	Non EU	35	31 (88.6)	1 (2.9)	3 (8.6)	0 (0.0)	0.178
MDR A. baumannii	EU	120	107 (89.2)	1 (0.8)	5 (4.2)	7 (5.8)	0.758
MDR A. baumannii	Non EU	33	31 (91.2)	0 (0.0)	2 (5.9)	1 (2.9)	0.758

^aFormerly positive for respective MDRO or presumptive infection/colonization with respective MDRO
^bCP only when certain risk factors present e.g. incontinence, diarrhoea, draining wounds
^cA two-sided p-value of < 0.05 was considered statistically significant

ISSN: 2047-2994